Outcomes of Retroperitoneoscopic Live Donor Nephrectomy (RPLDN): Experience of 1100 Cases at a Single Center
1Department of Urology, Tokyo Women's Medical University, Tokyo, Japan
2Department of Transplant Surgery, Toda Chuo General Hospital, Toda, Japan.
Meeting: 2018 American Transplant Congress
Abstract number: C132
Keywords: Graft function, Laparoscopy, Nephrectomy, Safety
Session Information
Session Name: Poster Session C: Kidney Living Donor Issues
Session Type: Poster Session
Date: Monday, June 4, 2018
Session Time: 6:00pm-7:00pm
Presentation Time: 6:00pm-7:00pm
Location: Hall 4EF
INTRODUCTION: Laparoscopic donor nephrectomy is a standard method of donor nephrectomy. We have tried to establish the technique of pure retroperitoneoscopic live donor nephrectomy (RPLDN) since 2001. In order to assess the safety, feasibility and usefulness of RPLND, we reviewed the experience of RPLND.
METHODS: From July 2001 to October 2016, 1106 patients underwent live donor renal transplants with allograft procured by RPLDN at our institute. Study variables included operative time, time to retrieval of the kidney, blood loss, warm ischemia time (WIT), hospital stay, graft function and complications.
RESULTS: Mean donor age was 56 ± 10 years. Two-hundred sixty patients (23.5%) had multiple renal arteries. Right kidneys were procured in 4.2% of cases. Mean operative time was 242 ± 95 min, WIT 4.4 ± 1.5 min, and mean blood loss 41 ± 54 ml. The number of total complications was 56 (5.1%). In two patients (0.2%) conversion to open nephrectomy was necessary. The number of patients which Clavien-Dindo classification of grade 1, 2, 3, 4, and 5 were 33 (3.0%), 10 (0.9%), 13 (1.2%), 0, and 0, respectively. Three patients (0.3%) were needed blood transfusion after RPLDN. Six patients (0.5%) with grade 3 complication were ureteral complication. There was no bowel complication, such as ileus or bowel injury. Serum creatinine levels in recipients at 7 and 14 days were 1.4 and 1.5 mg/dl on average, respectively. No patients required hemodialysis after transplantation due to the donor operation. Slow graft function was noted in 10 patients (0.9%).
CONCLUSIONS: Although the mean operative time was slight long, RPLDN can be performed with acceptable allograft function and early postoperative morbidity. The incidence of ureteral complication was extremely low.
CITATION INFORMATION: Omoto K., Okumi M., Kakuta Y., Noguchi H., Unagami K., Inui M., Ishida H., Tanabe K. Outcomes of Retroperitoneoscopic Live Donor Nephrectomy (RPLDN): Experience of 1100 Cases at a Single Center Am J Transplant. 2017;17 (suppl 3).
To cite this abstract in AMA style:
Omoto K, Okumi M, Kakuta Y, Noguchi H, Unagami K, Inui M, Ishida H, Tanabe K. Outcomes of Retroperitoneoscopic Live Donor Nephrectomy (RPLDN): Experience of 1100 Cases at a Single Center [abstract]. https://atcmeetingabstracts.com/abstract/outcomes-of-retroperitoneoscopic-live-donor-nephrectomy-rpldn-experience-of-1100-cases-at-a-single-center/. Accessed June 27, 2025.« Back to 2018 American Transplant Congress